ACUTE BIPHENOTYPIC LEUKEMIA
Clinical trials for ACUTE BIPHENOTYPIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE BIPHENOTYPIC LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE BIPHENOTYPIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells target Tough-to-Treat leukemia in early trial
Disease control OngoingThis early-stage study is testing a new type of CAR T-cell therapy for adults with acute myeloid leukemia (AML) or a related blood cancer that has come back or not responded to other treatments. Doctors take a patient's or a donor's immune cells, genetically modify them to better…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Frozen donor marrow tested as lifeline for blood cancer patients
Disease control TerminatedThis study aimed to test the safety and effectiveness of a bone marrow transplant for adults with certain blood cancers. The transplant would use frozen bone marrow tissue from unrelated, partially matched deceased donors. After the transplant, patients would take medications lon…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE1 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New hope to stop Leukemia's return after transplant
Disease control OngoingThis study is testing whether adding two drugs, venetoclax and azacitidine, after a stem cell transplant can help prevent high-risk leukemia from returning. It is for adults aged 18-75 with certain types of acute leukemia who have already had a transplant. The goal is to see if t…
Matched conditions: ACUTE BIPHENOTYPIC LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC